US Patent 10406146 Heterocyclic compound
Patent 10406146 was granted and assigned to Takeda Pharmaceutical Company on September, 2019 by the United States Patent and Trademark Office.
All edits
Edits on 17 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 9 Dec, 2023
Golden AI
Edits made to:
Article (+211 characters)
Article
Patent abstract
The present invention provides a heterocyclic compound having a HDAC inhibitory action, and useful for the treatment of inflammatory disease and the like, and a medicament comprising the compound.
Edits on 2 Oct, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Akira Kaieda0
Hiroshi Nara0
Masaki Daini0
Masato Yoshikawa0
Naoki Ishii0
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 3 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 25 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 28 Jan, 2022
Golden AI
Edits made to:
Infobox (+10 properties)
US Patent 10406146 Heterocyclic compound
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10406146
Date of patent
September 10, 2019
Patent application number
15754934
Date Filed
August 24, 2016
Patent citations
Patent primary examiner
Find more entities like US Patent 10406146 Heterocyclic compound
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
